NM_000440.3:c.1705C>A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_000440.3(PDE6A):c.1705C>A(p.Gln569Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,613,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000440.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE6A | ENST00000255266.10 | c.1705C>A | p.Gln569Lys | missense_variant | Exon 13 of 22 | 1 | NM_000440.3 | ENSP00000255266.5 | ||
PDE6A | ENST00000508173.5 | n.1889C>A | non_coding_transcript_exon_variant | Exon 11 of 20 | 1 | |||||
PDE6A | ENST00000613228.1 | c.1462C>A | p.Gln488Lys | missense_variant | Exon 11 of 20 | 5 | ENSP00000478060.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251448Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135900
GnomAD4 exome AF: 0.000120 AC: 176AN: 1461188Hom.: 0 Cov.: 31 AF XY: 0.000111 AC XY: 81AN XY: 726948
GnomAD4 genome AF: 0.000138 AC: 21AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74476
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30337596, 10393062, 31049658, 29343940, 26806561, 30998820, 31736247, 33057649, 33576794, 32037395, 21151602) -
PDE6A: PM3:Very Strong, PM2, PP3 -
- -
This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 569 of the PDE6A protein (p.Gln569Lys). This variant is present in population databases (rs139444207, gnomAD 0.03%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 10393062, 21151602, 29343940). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 167431). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PDE6A protein function. For these reasons, this variant has been classified as Pathogenic. -
Retinitis pigmentosa 43 Pathogenic:3
- -
- -
The PDE6A c.1705C>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PS1, PM2, PP3. Based on this evidence we have classified this variant as Likely Pathogenic. -
Retinitis pigmentosa Pathogenic:2
The PDE6A c.1705C>A (p.Gln569Lys) missense variant has been reported in two studies and is found in a total of five individuals with autosomal recessive retinitis pigmentosa, including one homozygote and four compound heterozygotes (Dryja et al. 1999; Avila-Fernandez 2010). The variant is also found in a heterozygous state in six unaffected relatives of the affected individuals. The p.Gln569Lys variant was absent from 70 controls but is reported at a frequency of 0.00026 in the Latino population of the Exome Aggregation Consortium. Based on the evidence, the p.Gln569Lys variant is classified as likely pathogenic for autosomal recessive retinitis pigmentosa. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
The p.Gln569Lys variant in PDE6A was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PS1, PM2. PP3. Based on this evidence we have classified this variant as Likely Pathogenic. If you have any questions about the classification please reach out to the Pierce Lab. -
PDE6A-related disorder Pathogenic:1
The PDE6A c.1705C>A variant is predicted to result in the amino acid substitution p.Gln569Lys. This variant has been reported many times in the compound heterozygous state in individuals with retinitis pigmentosa (see for examples Bryant et al. 2017. PubMed ID: 29343940; Ezquerra-Inchausti et al. 2018. PubMed ID: 30337596; Table S2 in Zampaglione et al. 2020. PubMed ID: 32037395). This variant is reported in 0.028% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-149274769-G-T). Given the evidence, we interpret c.1705C>A (p.Gln569Lys) as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at